TSHA   $4.535  3.07% Market Closed After Close 4.54 0.11%

Taysha Gene Therapies, Inc.
Total Cash 172.74M
totalCashPerShare 0.843
EBITDA -75.72M
Total Debt 58.30M
quickRatio 5.055
currentRatio 5.222
Total Revenue 12.87M
debtToEquity 53.554
Revenue/Share 0.064
ROA -0.34166
ROE -3.18686
grossProfits
freeCashflow -53.95M
operatingCashflow -75.37M
earningsGrowth
revenueGrowth -0.536
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -19.15378
profitMargins 0.0
enterpriseValue 145.84M
forwardPE -3.261905
floatShares 122.28M
sharesOutstanding 204.94M
sharesShort 20.70M
sharesShortPriorMonth 19.83M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.18%
heldPercentInstitutions 0.78%
Short Ratio help_outline 10.85%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 0.541
Price To Book help_outline 2.53
earningsQuarterlyGrowth
netIncomeToCommon -114.33M
trailingEps -0.49%
forwardEps -0.42%
enterpriseToEbitda -1.93
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 153
lastUpdated Nov. 7, 2024, 3:25 a.m.